Close menu




July 15th, 2025 | 07:05 CEST

Nasdaq-listed Almonty Industries receives substantial cash injection

  • Mining
  • Tungsten
  • Defense
  • nasdaqlisting
Photo credits: pixabay.com

Tungsten specialist Almonty Industries has capitalized on the momentum. Geopolitical risks and growing global concerns about raw material and security supply chains are increasingly leading Almonty to be seen as a reliable supplier and key provider of this critical metal in the West. With its listing on the US Nasdaq stock exchange, a significantly oversubscribed capital increase, and gross proceeds totaling USD 90 million, the Canadian company has moved up to a new league. It is now on a par with billion-dollar companies such as MP Materials in terms of securing scarce raw materials.

time to read: 1 minutes | Author: Stefan Feulner
ISIN: ALMONTY INDUSTRIES INC. | CA0203987072

Table of contents:


    Significantly Oversubscribed Offering

    It had already been anticipated. Yesterday, shares of Almonty Industries were traded for the first time on the US technology exchange Nasdaq. In addition, one of the world's leading tungsten producers announced the pricing of its US-guaranteed public offering of 20,000,000 common shares at an issue price of USD 4.50 per share. This will generate gross proceeds of USD 90 million for Almonty, enabling the Company, led by CEO Lewis Black, to enter into the next stage of its development. The offering is expected to close as early as today, subject to the fulfillment of customary closing conditions.

    The proceeds from the oversubscribed offering will be used to develop the tungsten oxide facility in Sangdong, further expanding the Company's position as a leading Western supplier of tungsten for the defense needs of the US and its allies. With the Sangdong mine in South Korea, which will celebrate the start of production later this year, more than 40% of the tungsten supply outside China is expected to be covered from 2027 onwards. Analyst Peter Thilo Hasler of Sphene Capital then expects revenues of CAD 483.4 million and EBIT of CAD 198.8 million.

    Strategic Move with Foresight

    With its own tungsten oxide production and smelting operations, Almonty Industries will be able to become completely independent of the Chinese refining market in the future. They will become the only fully integrated tungsten source in a region with a stable legal system, which would be a clear, unique selling point. The US government has already taken note of this. In an official letter, the US Congress emphasized the strategic importance of the Company for the supply of critical raw materials to the US.

    Sell on Good News

    Following the announcement of the Nasdaq listing and the capital raise, short-term investors took profits after a weeks-long rally, putting pressure on Almonty's share price and causing it to drop nearly 12% to CAD 6.96. In the long term, however, the decisions to relocate to the US, list on the Nasdaq, and implement a capital measure that has propelled the Company into new spheres are clearly positive. After a period of consolidation, a renewed surge is likely. The next milestone is the start of production, which is expected before the end of this year.

    Source: LSEG as of July 14, 2025

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Matthias Schomber on August 24th, 2026 | 08:20 CEST

    Cancer Breakthrough and Defense Boom: BioNTech and Moderna Take Off! Can Volatus Aerospace Follow Suit?

    • Drones
    • Defense
    • hightech
    • Cancer
    • Biotechnology

    In the capital markets, two entirely different future-oriented industries are simultaneously stepping into the spotlight. While in the biotech sector, hopes for groundbreaking cancer therapies are fueling a massive comeback for companies such as Moderna and BioNTech, a highly exciting turnaround candidate may be emerging in the specialized field of unmanned aviation. Investors are rightly asking themselves whether the recent optimism surrounding biotech stocks is underpinned by fundamental strength or whether it is merely a short-lived flash in the pan followed by a sell-off. Those who can now read the right signals in financial data and chart patterns may be able to identify which stocks are poised for the next major trend movements. We take a closer look for you.

    Read

    Commented by Armin Schulz on August 24th, 2026 | 08:00 CEST

    Potential Winners of the USD 1.4 billion Pentagon Deal: Rheinmetall, HPQ Silicon and BYD

    • Silicon
    • Batteries
    • Defense
    • Drones
    • Technology

    The Pentagon's USD 1.4 billion allocation to the US startup Sila Nanotechnologies for the development of silicon batteries is not a financial deal, but rather the starting signal for a new era in defense. The US military is aware that drones will dominate the battlefields of the future. Their performance is largely determined by the energy density of the battery cells. Silicon anodes promise advantages in terms of range and payload. The US and Europe have also recognized that they must reduce their dependence on Asian manufacturers for domestic supply chains. So today, we take a closer look at Rheinmetall's efforts, HPQ Silicon's latest innovations and BYD's battery activities.

    Read

    Commented by Fabian Lorenz on August 24th, 2026 | 07:45 CEST

    Sell Rheinmetall? Evotec with AI Potential and Lahontan Gold's 22% Resource Boost!

    • Mining
    • Gold
    • Silver
    • MRE
    • Commodities
    • Biotechnology
    • AI
    • Defense

    Should investors sell Rheinmetall shares? That is the recommendation from mwb research. The analysts continue to view Rheinmetall as a clear operational winner in the European defense boom. However, they believe market expectations starting in 2028 are too ambitious. The company's order backlog is not as robust as many assume. By contrast, there are strong arguments for a rising share price at Lahontan Gold. The gold price climbed back above USD 4,600, suggesting that a new rally in the precious metal could be getting underway—the perfect timing to give the Lahontan story a boost. The company plans to build a mine and begin gold production next year. Most recently, the resource estimate was raised by 22%. And what about Evotec? Its stock is at rock bottom. Can AI-driven optimism provide new momentum?

    Read